Related Articles
Astragaloside IV prevents damage to human mesangial cells through the inhibition of the NADPH oxidase/ROS/Akt/NF‑κB pathway under high glucose conditions
Astragaloside IV ameliorates diabetic nephropathy in <em>db/db</em> mice by inhibiting NLRP3 inflammasome‑mediated inflammation
Astragaloside IV prevents kidney injury caused by iatrogenic hyperinsulinemia in a streptozotocin‑induced diabetic rat model
Participation of the AngII/TRPC6/NFAT axis in the pathogenesis of podocyte injury in rats with type 2 diabetes
Lycopene attenuates high glucose‑mediated apoptosis in MPC5 podocytes by promoting autophagy via the PI3K/AKT signaling pathway